← E31.2

Chapter 4 - Endocrine, nutritional and metabolic diseases (E00-E89)»Disorders of other endocrine glands (E20-E35)»Multiple endocrine neoplasia [MEN] type IIA (E31.22)

E31.22

Multiple endocrine neoplasia [MEN] type IIA

Related indications (MeSH) (1)

Multiple Endocrine Neoplasia Type 2a5 drugs (4 approved, 1 experimental)

A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease.